Atara Biotherapeutics (ATRA) Capital Expenditures (QoQ) (2014 - 2023)
Atara Biotherapeutics (ATRA) Capital Expenditures (QoQ) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -890.75% |
| Sep 30, 2023 | -60.09% |
| Jun 30, 2023 | 262.89% |
| Mar 31, 2023 | 646.15% |
| Dec 31, 2022 | 126.80% |
| Sep 30, 2022 | 96.08% |
| Jun 30, 2022 | -194.93% |
| Mar 31, 2022 | 827.05% |
| Dec 31, 2021 | 111.71% |
| Sep 30, 2021 | -216.45% |
| Jun 30, 2021 | -6.19% |
| Mar 31, 2021 | 265.56% |
| Dec 31, 2020 | 19.48% |
| Sep 30, 2020 | -75.77% |
| Jun 30, 2020 | 55.74% |
| Mar 31, 2020 | -50.85% |
| Dec 31, 2019 | 6.44% |
| Sep 30, 2019 | 888.85% |
| Jun 30, 2019 | -140.58% |
| Mar 31, 2019 | 133.25% |